cilostamide has been researched along with Obesity in 3 studies
cilostamide: selective inhibitor of cyclic AMP phosphodiesterase & platelet aggregation; structure
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity is associated with the development of leptin resistance." | 7.72 | Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity. ( Bhatt, BA; Dedousis, N; Huang, W; O'Doherty, RM, 2004) |
| "Obesity is associated with the development of leptin resistance." | 3.72 | Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity. ( Bhatt, BA; Dedousis, N; Huang, W; O'Doherty, RM, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W | 1 |
| Dedousis, N | 1 |
| Bhatt, BA | 1 |
| O'Doherty, RM | 1 |
| Geoffroy, V | 1 |
| Fouque, F | 1 |
| Lugnier, C | 1 |
| Desbuquois, B | 1 |
| Benelli, C | 1 |
| Netherton, SJ | 1 |
| Jimmo, SL | 1 |
| Palmer, D | 1 |
| Tilley, DG | 1 |
| Dunkerley, HA | 1 |
| Raymond, DR | 1 |
| Russell, JC | 1 |
| Absher, PM | 1 |
| Sage, EH | 1 |
| Vernon, RB | 1 |
| Maurice, DH | 1 |
3 other studies available for cilostamide and Obesity
| Article | Year |
|---|---|
Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity.
Topics: Androstadienes; Animals; Chromones; Diet; Dose-Response Relationship, Drug; Enzyme Inhibitors; Insul | 2004 |
Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type | 2001 |
Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imi | 2002 |